The HIRN is pleased to announce the following grants have been awarded for RFA-DK-021 (CBDS) and
<br>
RFA-DK-17-022 (HPAC)
- "Development of an Early Diagnostic Biomarker and Novel Treatment Strategy for T1D" (CBDS: U01 DK120379)
- "Linking islet cell function and identity from in vitro to in situ" <br> (HPAC: U01 DK120447-01)
- "High-resolution characterization of human ductal progenitor cells and their regeneration potential" (HPAC: U01 DK120393-01)
- "Single cell analysis of the human pancreas in type 1 diabetes" b (HPAC: U01 DK120429)
- "In situ analysis of functional endocrine, vascular, and immune cell interactions during early postnatal development of the human pancreas" (HPAC: U01 DK120456-01)
|
|
MONTHLY INVESTIGATOR HIGHLIGHT
|
|
Get to know our new HIRN investigators
Select an investigator to view their profile
|
|
Benaroya Research Institute
|
|
|
Logos, Presentation Templates & Consortium Schematics
The HIRN official logos, powerpoint presentation templates and scientific consortium schematics are available for download on our website. Please download these for use on your presentations or as needed.
|
|
HIRN NIH Requests for Applications (RFAs)
- NIDDK intends to commit $4.5 million in FY 2019 to fund 1 award.
- Letter of Intent due: January 26, 2019
- Application due: February 26, 2019
RFA-DK-18-016
: Human Pancreas Analysis Program for Type 2 Diabetes (HPAP-T2D) (U01)
- NIDDK intends to commit $3 million in FY 2019 to fund 1 award.
- Letter of Intent due: January 26, 2019
- Application due: February 26, 2019
RFA-DK-18-011
: Human Islet Research Network: Consortium on Human Islet Biomimetics (CHIB)
- NIDDK intends to commit $3 million in FY 2019 to fund 2-3 awards.
- Letter of Intent due: November 11, 2018
- Application due: December 11, 2018
|
|
NIH Requests for Applications (RFAs)
NOT-RM-17-030
: T
he NIH Common Fund Regenerative Medicine Program (RMP) Announces the Opportunity to Collaborate with the Stem Cell Translation Laboratory (SCTL) at the National Center for Advancing Translational Sciences (NCATS)
- Proposal due dates: July 1, November 1 and March 1
RFA-PAR-18-886
:
New
Par
adigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional)
- Letter of Intent due: Six weeks prior to application due date
- Application due dates: Nov 1, 2019; May 30, 2019, October 31, 2019; June 2, 2020
RFA-DK-18-005
:
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
- NIDDK intends to commit $3.25 million in FY 2019 to fund 4-5 awards
- Letter of Intent due: November 6, 2018
- Application due: December 6, 2018
RFA-DK-17-031
:
The
Characterization and Discovery of Novel Autoantigens and Epitopes in Type 1 Diabetes (R01 Clinical Trial Optional)
- NIDDK intends to commit up to $1.25 million to fund 2-3 awards in FY 2018 and up to $1.25 million to fund 2-3 awards in FY 2019.
- Letter of Intent due: March 26, 2018 and November 6, 2018
- Application due: April 26, 2018 and December 6, 2018
|
|
Assistant & Associate Member
|
|
Postdoctoral Position
The
Lab of Dr. Abdelfattah El Ouaamari
at
Rutgers University/Robert Wood Johnson Medical School
is recruiting self-driven, creative and organized candidates with a PhD in neuroscience, biochemistry or molecular and cellular biology. The candidate must possess skills in manipulating and assessing neuronal activity. Candidates should have a strong record of productivity and publication in the fields of neuroscience/neurobiology or islet biology. Interested candidate should send CV, cover letter and 3 references directly to
Dr. El Ouaamari
.
|
|
Postdoctoral Associate
The
University of Miami
in the Lab of Dr. Joana Almaca is accepting applications for a
Postdoctoral Associate
to focus on the role of microvasculature in type 1 diabetes. Strong scientific background in molecular physiology and demonstrated scientific problem solving ability and creativity. Experience in confocal microscopy, calcium imaging and image quantification is highly desired. Send detailed CV, list of publications and statement of research directly to
Dr. Joana Almaca
.
|
|
Postdoctoral Fellow
The lab of Dr. Joe Zhou is accepting applications for a
Postdoctoral Fellow
position at
Weill Cornell Medicine
starting in the spring of 2019. The candidate should have a PhD or MD degree, and at least one first-author publication that demonstrates proficiency in research. He/she should have vigorous training in at least one of the following fields: stem cell biology, molecular biology, biochemistry, neuroscience, proteomics, or mouse genetics. Send CV and contact information directly to
Dr. Joe Zhou
.
|
|
|
2019 Annual Investigator Meeting
Save the date for the 2019 HIRN Annual Investigator meeting. It will be held on April 28-May 1, 2019 at the Capital Hilton, Washington DC.
|
|
Gordon Research Conference
The 2019 Gordon Conference on Pancreatic Diseases will be
June 16-21, 2019 at the Jordan Hotel at Sunday River in Newry, ME.
|
|
|
Click subscribe to join the mailing list for our monthly HIRN newsletter
|
|
|
|
|
|
|